Analysis of FDA’s October 17, 2017 “Basis for the recommendations to control mitragynine and 7-hydroxymitragynine in Schedule I of the Controlled Substances Act"

Henningfield JE, Babin J, Boyer EW, Brown P, Garcia-Romeu A, Griffiths RR,
Grundmann O, Hemby SE, McCurdy CR, Raffa RB, Swogger MT, Walsh Z

November 28, 2018


View PDF